AC
AVNS

AXQ Capital’s Avanos Medical AVNS Stock Holding History

AXQ Capital’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-27,757
Closed -$312K – 1000
2025
Q4 		$312K Sell
27,757
-2,906
-9% -$33.3K 0.07% 432
2025
Q3 		$354K Buy
30,663
+7,443
+32% +$87.2K 0.14% 270
2025
Q2 		$284K Sell
23,220
-1,432
-6% -$18K 0.09% 378
2025
Q1 		$353K Buy
+24,652
New +$385K 0.14% 254

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

AXQ Capital's AVNS Position: Q1 2026 in Review

AXQ Capital sold out of Avanos Medical (AVNS) in Q1 2026, closing a stake of 27,757 shares — an estimated $312K sold.

AXQ Capital first reported a position in AVNS in Q1 2025 and held it in 4 quarters. The position peaked at $354K in Q3 2025. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

  • AXQ Capital reported no remaining Avanos Medical position as of Q1 2026 after selling out during the quarter.
  • AXQ Capital sold 27,757 Avanos Medical shares in Q1 2026, an estimated $312K.
  • AXQ Capital first reported a position in Avanos Medical in Q1 2025 and held it in 4 quarters.
  • AXQ Capital's Avanos Medical position peaked at $354K in Q3 2025.
  • 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on AXQ Capital's 13F filing for Q1 2026, filed 13 May 2026.